OptimizeRx Corp Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2014 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
OptimizeRx Corp quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2014 to Q3 2024.
  • OptimizeRx Corp Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 18.3M shares, a 10.1% increase year-over-year.
  • OptimizeRx Corp annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 17.1M shares, a 3.71% decline from 2022.
  • OptimizeRx Corp annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 17.8M shares, a 3.23% increase from 2021.
  • OptimizeRx Corp annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 17.2M shares, a 16.2% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 18.3M +1.69M +10.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 18.3M +1.27M +7.45% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-15
Q1 2024 18.2M +1.08M +6.29% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 17.1M -659K -3.71% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-15
Q3 2023 16.6M -1.34M -7.47% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 17M -1.13M -6.24% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-15
Q1 2023 17.1M -783K -4.38% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 17.8M +556K +3.23% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-15
Q3 2022 18M +342K +1.94% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 18.1M +775K +4.47% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 17.9M +1.78M +11% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 17.2M +2.4M +16.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 17.6M +2.74M +18.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 17.3M +2.68M +18.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 16.1M +1.49M +10.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 14.8M +1.44M +10.8% Oct 1, 2020 Dec 31, 2020 10-K/A 2023-03-10
Q3 2020 14.9M +754K +5.33% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 14.7M +1.92M +15.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 14.6M +2.53M +21% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 13.4M +2.56M +23.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-08
Q3 2019 14.1M +2.39M +20.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 12.7M +1.76M +16.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 12.1M +2.29M +23.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 10.8M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 11.8M +2M +20.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 11M +1.12M +11.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 9.79M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q3 2017 9.75M -19.7M -66.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 9.86M -19.3M -66.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q3 2016 29.4M +6.17M +26.5% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-07
Q2 2016 29.1M +6.22M +27.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q3 2015 23.3M -103K -0.44% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 22.9M -317K -1.36% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q3 2014 23.4M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 23.2M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.